TY - JOUR AU - Krishnasis Chakraborty PY - 2019/09/15 Y2 - 2024/03/29 TI - A New Drug Approval Process in Europe: A Review JF - International Journal of Drug Regulatory Affairs JA - Int J Drug Reg Affairs VL - 7 IS - 3 SE - Review DO - 10.22270/ijdra.v7i3.332 UR - https://ijdra.com/index.php/journal/article/view/332 AB - Current constrain of Regulatory Affairs reveals diverse countries need to follow different regulatory requirements for Marketing Authorization Application (MAA) approval of new drugs. In this present exertion, study expresses the drug approval process and Regulatory requirements according to European Medical Agency (EMA) (1). ER -